亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A Fully Replicate, Cross-over, Bioequivalence Study to Compare Two Prolonged Release, Multi-matrix Tablet Formulations of Budesonide in Healthy Indian Adults

生物等效性 布地奈德 医学 药代动力学 生物利用度 耐受性 皮质类固醇 内科学 药理学 胃肠病学 不利影响
作者
Ankith Rai,Kushal Sarda,Lokesh Yadav,Anadya Prakash Tripapathi,Sachin Joshi,Rajan Verma,Manisha Patil,Nilesh Lad
出处
期刊:Journal of Clinical and Diagnostic Research [JCDR Research and Publications Private Limited]
被引量:1
标识
DOI:10.7860/jcdr/2023/60894.17660
摘要

Introduction: Budesonide is a synthetic, non halogenated corticosteroid, structurally related to 16α-hydroxyprednisolone, which is approved as first-line therapy for various gastrointestinal disorders. Budesonide prolonged-release tablets incorporating multi-matrix technology {Cortiment® 9 mg: Reference product (R)} were approved in India for induction of remission in adult patients with mild-to-moderate active ulcerative colitis. Aim: To assess the bioavailability, safety and tolerability of a single dose of generic budesonide prolonged-release tablets 9 mg {CortirowaTM OD; Test product (T)} and demonstrate their bioequivalence to Reference product (R) in healthy Indian adults under fasting conditions. Materials and Methods: In this randomised, open-label, single-dose, balanced, 2-treatment, 2-sequence, 4-period, fully replicate, cross-over bioequivalence study conducted from 12 July 2021 to 08 August 2021 at Ecron Acunova Limited, Manipal, India, 56 participants were randomly allocated (1:1) to treatment sequences Test-Reference-Test-Reference (TRTR) or Reference-Test-Reference-Test (RTRT). After a 10-hour overnight fast, participants were administered a single oral dose of T or R along with 240 mL of water. After each dose, a total of 26 venous blood samples (each 4 mL) were collected from each participant, at hourly intervals until 20 hours, and at 24, 30, 36, 48, and 72 hours. Plasma budesonide concentrations were analysed using a validated Liquid ChromatographyTandem-Mass Spectrometry (LC-MS/MS) method. Based on the randomisation sequences, the treatment periods were defined as test product treatment Period-1 (T1), test product treatment Period-2 (T2), reference product treatment Period-1 (R1), and reference product treatment Period-2 (R2). The primary pharmacokinetic parameters were peak plasma concentration (Cmax) and area under the concentration-time curve from time zero to the last sample with quantifiable concentration (AUC0-t). Results: Test and reference products were comparable in terms of mean (standard deviation) Cmax {pg/mL: T1=2163.0 (1423.9) and T2=2456.25 (1346.035) vs R1=2301.59 (1582.995) and R2=2437.62 (1437.665)} and AUC0-t {hr.pg/mL: T1=27938.0 (16431.23) and T2=33629.58 (18407.253) vs R1=25882.41 (17250.267) and R2=33146.25 (19350.222)}. As the within-subject Standard Deviation (SD) of R (SWR) for Cmax and AUC0-t was ≥0.294, the reference-Scaled Average Bioequivalence (SABE) approach was used. The bioequivalence criteria prespecified using the Scaled Average Bioequivalence (SABE) approach were met as the 95% upper confidence bound for (μT-μR)2 - θs2 WR of Cmax (-0.255371831) and AUC0-t (-0.445865013) were both ≤0, and the point estimate (T/R) geometric mean ratio of Cmax (0.97) and AUC0-t (1.06) were both within 0.80 and 1.25. While 10 Adverse Events (AEs) were reported in the study, all were of mild intensity. Conclusion: CortirowaTM OD was bioequivalent to Cortiment® 9 mg in healthy Indian adults under fasting conditions. Both the products were found to be well tolerated.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiahou发布了新的文献求助10
6秒前
xiahou完成签到,获得积分10
26秒前
踏实的白卉完成签到,获得积分10
29秒前
虚心含海完成签到,获得积分10
38秒前
执着忆寒完成签到,获得积分10
1分钟前
1分钟前
拼搏静槐完成签到,获得积分10
1分钟前
无情棒棒糖完成签到 ,获得积分10
1分钟前
1分钟前
bkagyin的应助被SUNny采纳,获得10
2分钟前
认真雨寒完成签到,获得积分10
2分钟前
2分钟前
2分钟前
明理紫萍完成签到,获得积分10
2分钟前
正直盼秋完成签到,获得积分10
3分钟前
欢呼的馒头完成签到,获得积分10
3分钟前
JoyEn完成签到,获得积分10
3分钟前
zhangzhangzhang完成签到,获得积分20
3分钟前
无奈的琦完成签到,获得积分10
4分钟前
英俊的铭的应助被36hours采纳,获得100
4分钟前
李健的应助被36hours采纳,获得200
4分钟前
魔幻雅柔完成签到,获得积分10
4分钟前
4分钟前
monthli发布了新的文献求助10
4分钟前
标致的忆梅完成签到,获得积分10
4分钟前
所所的应助被强健的绿蕊采纳,获得10
4分钟前
大个的应助被36hours采纳,获得200
4分钟前
Maestro_S的应助被SUNny采纳,获得10
5分钟前
清爽笙完成签到,获得积分10
5分钟前
5分钟前
FashionBoy的应助被wggggggy采纳,获得10
5分钟前
5分钟前
天天快乐的应助被呵呵采纳,获得20
5分钟前
5分钟前
跳跃的咖啡豆完成签到,获得积分10
5分钟前
wggggggy发布了新的文献求助10
5分钟前
5分钟前
呵呵发布了新的文献求助20
5分钟前
leoo完成签到,获得积分10
5分钟前
复杂的雁芙完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166261
求助须知:如何正确求助?哪些是违规求助? 9559448
关于积分的说明 21750400
捐赠科研通 7757056
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553442
邀请新用户注册赠送积分活动 2473787